Patents by Inventor Brian Raimundo

Brian Raimundo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclic compounds useful as GPR120 modulators
    Patent number: 11919891
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: March 5, 2024
    Assignee: Valo Health, Inc.
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
    Publication number: 20230183231
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Application
    Filed: October 3, 2022
    Publication date: June 15, 2023
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • Monocyclic compounds useful as GPR120 modulators
    Patent number: 11548886
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: January 10, 2023
    Assignee: Valo Health, Inc.
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • BICYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
    Publication number: 20210347768
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Application
    Filed: December 14, 2020
    Publication date: November 11, 2021
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
    Publication number: 20210101896
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Application
    Filed: August 20, 2020
    Publication date: April 8, 2021
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • Bicyclic compounds useful as GPR120 modulators
    Patent number: 10865201
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: December 15, 2020
    Assignee: Valo Health, Inc.
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • Monocyclic compounds useful as GPR120 modulators
    Patent number: 10800773
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: October 13, 2020
    Assignee: Integral Health, Inc.
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • BICYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
    Publication number: 20190218208
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Application
    Filed: September 11, 2017
    Publication date: July 18, 2019
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
    Publication number: 20190202821
    Abstract: Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
    Type: Application
    Filed: September 11, 2017
    Publication date: July 4, 2019
    Inventors: Brian Raimundo, Elena S. Koltun, John Griffin, Eric Stangeland
  • HETEROARYL COMPOUNDS USEFUL AS RAF KINASE INHIBITORS
    Publication number: 20120040951
    Abstract: The present invention provides compounds of formula (I) useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
    Type: Application
    Filed: December 30, 2009
    Publication date: February 16, 2012
    Inventors: Claudio Chuaqui, Jennifer Cossrow, James Dowling, Bing Guan, Michael Hoemann, Alexey Ishchenko, John Howard Jones, Lori Kabigting, Gnanasambandam Kumaravel, Hairuo Peng, Noel Powell, Brian Raimundo, Hiroko Tanaka, Kurt van Vloten, Jeffrey Vessels, Zhili Xin
  • PYRIDO PYRIMIDINONES, DIHYDRO PYRIMIDO PYRIMIDINONES AND PTERIDINONES USEFUL AS RAF KINASE INHIBITORS
    Publication number: 20110059976
    Abstract: The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: and n, R1, R2, R3, R4, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., RAF), and thus are useful, for example, for the treatment of RAF mediated diseases.
    Type: Application
    Filed: July 26, 2010
    Publication date: March 10, 2011
    Inventors: Johan D. Oslob, Jiang Zhu, Kenneth Barr, Jennifer Cossrow, Brian Raimundo, Hiroko Tanaka
  • Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
    Patent number: 7767687
    Abstract: The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: n, R1, R2, R3, R4, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., RAF), and thus are useful, for example, for the treatment of RAF mediated diseases.
    Type: Grant
    Filed: December 12, 2005
    Date of Patent: August 3, 2010
    Assignees: Biogen Idec MA Inc., Sunesis Pharmaceuticals, Inc.
    Inventors: Johan D. Oslob, Jiang Zhu, Kenneth Barr, Jennifer Cossrow, Brian Raimundo, Hiroko Tanaka
  • Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as Raf kinase inhibitors
    Publication number: 20060211702
    Abstract: The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: n, R1, R2, R3, R4, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., RAF), and thus are useful, for example, for the treatment of RAF mediated diseases.
    Type: Application
    Filed: December 12, 2005
    Publication date: September 21, 2006
    Inventors: Johan Oslob, Jiang Zhu, Kenneth Barr, Jennifer Cossrow, Brian Raimundo, Hiroko Tanaka